loader

World Tenders & Procurement Opportunities

Search
Advanced Search

728502- Germany – Pharmaceutical products – Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 of the German Social Code, Book V (SGB V) for medicinal products containing the active ingredient abatacept (ATC code: L04AA24) .

World Biggest Tenders Source

This tender with title 728502- Germany – Pharmaceutical products – Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 of the German Social Code, Book V (SGB V) for medicinal products containing the active ingredient abatacept (ATC code: L04AA24) . has been published on Bidding Source portal dated 06 Nov 2025 for the country of Germany. It has been categorized on Pharmaceutical products. For similar tenders you can see tenders mentioned below of this page.

General Information

Germany

728502- Germany – Pharmaceutical products – Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 of the German Social Code, Book V (SGB V) for medicinal products containing the active ingredient abatacept (ATC code: L04AA24) .
Invitation for Bids
728502
Germany
6 Nov 2025
27 Oct 2027
English
Pharmaceutical products

For viewing full details of tenders, you should Log in to your account. If not registered yet, Please Register Now

Or Request a call back now and one of our representatives will contact you. Contact us

Similar Tenders

729066- Germany – Pharmaceutical products – Conclusion of non-exclusive discount agreements pursuant to Section 130a Paragraph 8 of the German Social Code, Book V (SGB V) with the active ingredient pazopanib Germany 733161- Germany – Pharmaceutical products – Conclusion of non-exclusive discount agreements pursuant to Section 130a Paragraph 8 of the German Social Code, Book V (SGB V) for the aforementioned active ingredients, with the option of concluding such agreements within the framework of the so-called open-house procedure. Germany 733452- Germany – Pharmaceutical products – Conclusion of non-exclusive discount agreements pursuant to Section 130a Paragraph 8 of the German Social Code, Book V (SGB V) for the aforementioned active ingredients, with the option of concluding such agreements within the framework of the so-called open-house procedure. Germany 729232- Germany – Pharmaceutical products – Conclusion of non-exclusive discount agreements pursuant to Section 130a Paragraph 8 of the German Social Code, Book V (Open-House Model) Germany Delivery of medical supplies for the rescue service in the Steinfurt district - 5055958 Germany 727715-Awarded - Germany – Pharmaceutical products – Conclusion of a non-exclusive discount agreement pursuant to Section 130c Paragraph 1 of the German Social Code, Book V (SGB V) between IKK classic and EurimPharm Arzneimittel GmbH for Skyrizi(R) Germany 724803- Germany – Pharmaceutical products – Conclusion of discount agreements pursuant to Section 130a Paragraph 8 of the German Social Code, Book V (SGB V) for pharmaceuticals in the generic market Germany 725135-Awarded - Germany – Pharmaceutical products – Medikamentenversorgung Germany 722278- Germany – Pharmaceutical products – Conclusion of a non-exclusive drug discount agreement pursuant to Section 130a Paragraph 8 of the German Social Code, Book V, by way of an open-house model for the active ingredient colistin (WHO ATC code: J01XB01) Germany 722611- Germany – Pharmaceutical products – Conclusion of a non-exclusive drug discount agreement pursuant to Section 130a Paragraph 8 of the German Social Code, Book V, by way of an open-house model for the active ingredient lactulose (WHO ATC code: A06AD11) Germany
Pharmaceutical products Tenders
Germany Tenders
Europe Tenders
Tenders
No. 12, 1 st floor, Block B2, EGS Business Park, World Trade Center, Bakirkoy - Istanbul - Turkey
info@biddingsource.com
24 X 7 online support
TOP
For viewing latest tenders published for your business in all over the World: Sign in Join free
For accessing full details of Tenders, Kindly choose the Plan that works for you: View Subscription Plans